订阅小程序
旧版功能

HELIX-ICC: An-open Label Phase II Trial of Induction Systemic Mfolfirinox Followed by Concurrent Hepatic Arterial Infusion of Floxuridine and Systemic Mfolfiri for Unresectable Intrahepatic Cholangiocarcinoma

JOURNAL OF CLINICAL ONCOLOGY(2022)

引用 0|浏览39
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要